ALAN THOMAS: Open Payments
NPI 1821142647 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,098 in 158 payments from 38 companies in 2025. Trend: 2023 $1,461 · 2024 $2,159 · 2025 $3,098
Food & beverage: $3,098
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 19 | $225 |
| Janssen Biotech, Inc. | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 13 | $201 |
| Daiichi Sankyo Inc. | 10 | $180 |
| SOBI, INC | 9 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $167 |
| Exelixis Inc. | 5 | $132 |
| PFIZER INC. | 7 | $123 |
| Merck Sharp & Dohme LLC | 5 | $118 |
| Stemline Therapeutics Inc. | 4 | $107 |
Products named: Vyloy, FRUZAQLA, Vonjo, CABOMETYX, PLUVICTO, KEYTRUDA, Enhertu, Orserdu.
Industry payments across CA — which companies pay providers there.
